A refusal to test is one of the most consequential events in a DOT drug and alcohol testing program. Under 49 CFR Part 40.305, a refusal to test is treated exactly the same as a verified positive result. The employee must be immediately removed from safety-sensitive duties, referred to a Substance Abuse Professional, and cannot return to a DOT safety-sensitive role until completing the full return-to-duty process.
What complicates the refusal is that many DERs are uncertain about what actually constitutes one. Not every collection difficulty is a refusal. Some situations that appear to be refusals have a legitimate medical explanation and a defined regulatory path. Others that seem ambiguous are clear-cut refusals under Part 40 that the DER is required to act on immediately.
This guide defines what constitutes a refusal to test under 49 CFR Part 40, how refusals are documented, and the step-by-step response the DER must take. For a full overview of the DER role across all testing categories, see DER Support Services.
Key Takeaways
- A refusal to test under DOT regulations is treated exactly the same as a verified positive result under 49 CFR Part 40.305. The employee must be removed from safety-sensitive duties immediately.
- Refusals are defined broadly under 49 CFR Part 40.191 and include conduct beyond simply saying “no.” Failure to appear, leaving the collection site, tampering with a specimen, and a three-hour failure to provide a sufficient urine specimen all constitute refusals.
- Shy bladder is not automatically a refusal. The employee has up to three hours to provide a sufficient specimen and may drink up to 40 ounces of water during that period. Only if the employee cannot provide a specimen after three hours is the situation documented as a refusal.
- The collector documents the refusal and notifies the DER immediately. The DER makes the determination and, if appropriate, then takes the same steps required for a verified positive result.
- For FMCSA-regulated CDL drivers, the DER is responsible for reporting refusals to the FMCSA Clearinghouse within two business days of the refusal.
- An employee who is determined to have refused to test because they couldn’t provide a sufficient quantity of a specimen within the 3-hour allotted time period may contest the outcome by seeking a medical evaluation to document a physiological condition that prevents specimen collection. This does not suspend the removal requirement.
What Constitutes a Refusal to Test Under 49 CFR Part 40
The definition of a refusal to test is broader than most DERs initially expect and more nuanced than a simple checklist. Under 49 CFR Part 40.191, a refusal can take many forms, but the regulation does not always make clear that, in most cases, the DER has significant discretion to determine whether a refusal has actually occurred. With one notable exception – the three-hour shy bladder window, where the MRO takes the lead – it is the DER’s judgment call. Some situations are straightforward. Others require the DER to evaluate the facts, weigh the circumstances, and make a determination. The sections below identify each refusal category and how the DER should evaluate the decision.
Failure to Appear for Testing
An employee who fails to report to the collection site within the time required by the employer may be determined to have refused to test, but this category requires the DER to exercise judgment. For random testing, employees must proceed immediately after notification without advance notice. For post-accident testing, the employer must initiate the collection as soon as possible. When an employee does not appear, the DER must evaluate whether the failure was intentional. If the DER concludes the employee was deliberately avoiding the test, a refusal determination is appropriate. If there is a credible, documented explanation for the failure to appear, the DER has discretion in how to proceed. The DER’s determination and the reasoning behind it should be documented regardless of outcome.
The DER should document the time of employee notification and the time the collection site confirmed the employee did not appear. This documentation is the basis for the refusal determination.
Leaving the Collection Site Before the Process Is Complete
An employee who arrives at the collection site but leaves before the collection is complete has refused to test. This includes leaving during the observation period, leaving after the specimen was collected but before documentation is complete, or departing at any point before the collector releases the employee from the collection process. This category is relatively straightforward, with one significant exception. The collector is required to explicitly inform the employee that leaving before the process is complete will be treated as a refusal, and to explain what a refusal means in terms of consequences. If the collector failed to issue that warning clearly, the DER may have grounds to override the refusal determination. The completeness and clarity of the collector’s documentation is therefore critical to supporting the DER’s decision.
Collectors are trained to document departures in real time. When a departure from the collection site is reported, the DER or the C/TPA on the DER’s behalf, should contact the collector directly to gather the facts needed to support the refusal determination. The collector’s documentation on the chain-of-custody form is the basis for that decision, and the DER should ensure it is complete and unambiguous before proceeding.
Failure to Provide a Sufficient Specimen: Shy Bladder
Shy bladder, the inability to provide sufficient urine volume (45 mL) at the time of collection, is not automatically a refusal. The regulatory process for shy bladder gives the employee a structured opportunity to provide a specimen.
Under 49 CFR Part 40.193, when an employee cannot provide a sufficient specimen on the first attempt, the collector discards the insufficient specimen, provides the employee with up to 40 ounces of water to drink over a period of no more than three hours, and waits for the employee to make another attempt. The employee must remain at the collection site during this period. Most shy bladder situations resolve within 90 minutes.
If the employee cannot provide a sufficient specimen after three hours, the collector documents the outcome and reports it as a refusal to test. The employee may contest this outcome by obtaining a medical evaluation from a licensed physician within a specified timeframe, which can determine whether a genuine physiological condition prevented the employee from providing a specimen. This is the notable exception in refusal determinations where the DER has minimal control over the outcome. The MRO reviews the medical evaluation and is the only party that can overturn the refusal result, and only if the medical evidence is sufficiently compelling. The DER cannot independently override a shy bladder refusal determination.
The DER should be notified by the collector when an employee enters the shy bladder process (though this notification is not common in practice), particularly as the three-hour window approaches. A DER who is reachable and informed can ensure the collection site follows the correct protocol and that documentation is complete.
Tampering, Adulteration, or Substitution of a Specimen
It is important to distinguish between observed tampering at the collection site and lab-confirmed adulteration or substitution results. When a laboratory determines through specimen validity testing that a specimen was adulterated or substituted, the MRO reviews the finding and, if confirmed, reports it to the DER. These are not refusals to test; they are legitimate MRO-confirmed results, and they are treated as positive results, not as refusals. The DER should understand this distinction when reviewing result categories, as the compliance response for a positive result and a refusal to test may differ.
Observed tampering at the collection site, such as attempts to introduce a foreign substance into the specimen or to use a synthetic product, is documented by the collector in real time. Even in these cases, it remains the DER’s responsibility to make the ultimate refusal determination. The collector’s thorough and specific documentation is critical here, as it removes doubt about the basis for the determination and supports the DER’s decision if the refusal is ever challenged.
Refusing to Sign the Chain-of-Custody Form
An employee who refuses to sign the federal custody and control form (CCF) at the collection site has refused to test. The employee’s signature on the CCF confirms that the specimen was collected and that the information matches their identification. It does not indicate consent to testing or acceptance of the result. Refusing to sign is documented by the collector as a refusal.
Refusing to Undergo an Observed Collection When Required
Under 49 CFR Part 40.67, certain circumstances require a directly observed collection, including return-to-duty testing and follow-up testing. An employee who refuses to allow a directly observed collection when one is required has refused to test. Collectors are required to explain to the employee why the observed collection is being conducted and to obtain the employee’s agreement to proceed. At this stage, refusal is documented as a refusal to test.
Failure to Cooperate With the Testing Process
More broadly, any employee conduct that prevents the completion of a valid test may constitute a refusal. This includes refusing to remove clothing for an observed collection, engaging in conduct that disrupts or interferes with the collection process, or failing to follow the collector’s instructions. These situations are less common but should be documented carefully by the collector and reported to the DER immediately.
What Is Not Automatically a Refusal to Test
A legitimate shy bladder situation within the three-hour window is not a refusal. The employee has a three-hour period to consume up to 40 ounces of water before making another attempt. Until that window closes without a sufficient specimen, the DER should not treat the situation as a refusal.
A collection site error or documentation issue is not a refusal by the employee. If the collection site is closed, paperwork is missing, or the pre-authorization form contains an error, these are administrative issues to be resolved through the C/TPA, not employee refusals.
An employee who disagrees with being selected for testing has not refused to test simply by expressing objection. The refusal occurs when the employee takes an action or fails to take an action that prevents the test from being completed. An employee who shows up, complains about the selection, but completes the collection has not refused.
A medical condition that prevents specimen provision may serve as grounds to contest a shy bladder refusal outcome, but must be documented by a licensed physician through the regulatory process after the refusal determination is made. The DER should not unilaterally decide that an employee’s claimed medical condition prevents a refusal determination.
How a Refusal Is Documented and How the DER Is Notified
When a refusal occurs at the collection site, the collector documents it in real time on the chain-of-custody form and immediately notifies the employer’s DER. Immediate notification is a regulatory requirement, not a courtesy call.
The collector documents the specific behavior or failure that constitutes the refusal, the time it occurred, and any relevant context. For situations involving adulteration or substitution, the collector’s on-site observation is supplemented by the laboratory’s validity testing results, which are reviewed by the MRO before the refusal is reported to the DER.
It is important to note that the regulatory requirement is that the collector contact the DER directly, not route communications through a C/TPA. PROCOM’s contact information is printed on every pre-authorization form as a resource for the collection site, and PROCOM does its best to support the process. However, PROCOM’s role is supportive, not intermediary. The required contact runs from collector to DER, and that chain should not be disrupted. For after-hours testing situations involving a refusal, PROCOM’s 24/7 after-hours team is available by direct phone to assist the DER in coordinating the response.
The DER’s Step-by-Step Response to a Refusal
Step 1: Immediately Remove the Employee From Safety-Sensitive Duties
Upon receiving notification of a refusal to test, the DER must immediately remove the employee from all safety-sensitive functions under 49 CFR Part 40.305. The refusal is treated the same as a verified positive result for purposes of the removal action. However, as noted throughout this guide, it remains the DER’s responsibility to make the ultimate determination of refusal based on the available facts. Removing the employee from duty and finalizing the refusal determination are two distinct steps; the DER can and should act on the removal immediately while gathering the information needed to support the determination. The MRO’s report, or any other confirmation before removing the employee from duty. For a full description of the removal requirement and the DER’s authority, see DER Support Services.
Step 2: Inform the Employee That the Refusal Is Treated as a Positive Result
The DER notifies the employee that the refusal has been documented and that it is treated under DOT regulations the same as a verified positive drug test result. The DER should inform the employee of their right to seek a medical evaluation if the refusal was based on a claimed inability to provide a specimen.
Step 3: Report to the FMCSA Clearinghouse for CDL Drivers
For FMCSA-regulated CDL drivers, the DER is responsible for reporting the refusal to the FMCSA Drug and Alcohol Clearinghouse within two business days. This is the DER’s reporting obligation; unlike positive drug test results, which the MRO reports to the Clearinghouse, refusals are reported by the employer through the DER.
Step 4: Provide a SAP Referral
The DER provides the employee with a list of qualified Substance Abuse Professionals or a resource for finding one. The employee selects the SAP. The DER does not choose the SAP for the employee. The SAP evaluates the employee, determines the required clinical interventions, and specifies the minimum follow-up testing requirements before the employee can return to a safety-sensitive role.
Step 5: Document Every Step
The DER maintains documentation of the refusal notification, the time the employee was removed from duty, the Clearinghouse report for FMCSA drivers, the SAP referral, and any subsequent return-to-duty activity. This documentation follows the same retention schedule as other drug and alcohol testing records, five years for most records under DOT regulations. Refusal situations are often time-sensitive and can quickly become compliance issues if handled incorrectly. Having a documented response process and experienced support when questions arise helps employers respond consistently, protect public safety, and remain audit-ready.
Need Support With Refusal Situations and DER Compliance?
PROCOM provides:
- ✔ Direct DER access for immediate support during refusal situations
- ✔ 24/7 after-hours collection coordination, including refusal documentation support
- ✔ Clearinghouse reporting support for FMCSA-regulated programs
- ✔ Full C/TPA program management, including collection authorization and chain-of-custody oversight
- ✔ Audit-ready documentation for every testing event
Contact PROCOM to establish a company account, discuss your testing program, or get support for an active situation. DER Support Services | Consortium and TPA Services
📞 303-325-3010 | 📧 michelle@procomtesting.com
Related Services: DER Support Services | Consortium and TPA Services | DOT Drug and Alcohol Testing | What Is an MRO? | View All Services
Compliance Resources: 49 CFR Part 40 | FMCSA Drug and Alcohol Rules | FMCSA Clearinghouse | DOT Agency Requirements
Service Areas: Denver | Colorado Springs | Pueblo | Grand Junction | Glenwood Springs | View All Service Areas
Regulatory Disclaimer: This content is provided for general informational and educational purposes regarding DOT and workplace drug and alcohol testing requirements. It does not constitute legal advice, official DOT regulatory interpretation, or company-specific compliance guidance. DOT drug and alcohol testing regulations are established under 49 CFR Part 40 and DOT agency-specific regulations and are subject to amendment. Always verify you are applying current regulations and consult qualified legal counsel for definitive compliance requirements. PROCOM Testing provides DOT and non-DOT drug and alcohol testing services in accordance with 49 CFR Part 40. Compliance with drug and alcohol testing regulations is the employer’s responsibility.
PROCOM Testing | DOT-Qualified Collectors | SAMHSA-Certified Lab Partnerships | In-House MRO Services
Frequently Asked Questions About DOT Test Refusals
Yes. Under 49 CFR Part 40.305, a refusal to test is treated exactly the same as a verified positive result. The employee must be immediately removed from safety-sensitive duties, referred to a Substance Abuse Professional, and cannot return to a DOT safety-sensitive role until completing the full return-to-duty process, including a directly observed return-to-duty test and a minimum of six unannounced follow-up tests in the first 12 months.
No. A refusal under 49 CFR Part 40.191 includes conduct, not just verbal statements. Failing to appear, leaving the collection site, refusing to sign the chain-of-custody form, providing an adulterated or substituted specimen, and failing to provide a sufficient specimen within three hours are all refusals regardless of whether the employee verbally states a refusal.
If the three-hour shy bladder window has closed without a sufficient specimen, the situation is documented as a refusal to test. The employee may pursue a medical evaluation by a licensed physician to document a physiological condition that prevented the provision of a specimen. This evaluation must follow the regulatory process and is not a unilateral decision for the DER. The DER should follow the refusal response protocol, including removal from duty, while the employee pursues any medical contest through the appropriate channels.
No. The removal from safety-sensitive duty is effective immediately upon the determination of refusal. Disputing the refusal does not suspend the removal. If the refusal determination is ultimately resolved in the employee’s favor through the regulatory contest process, the employee may be eligible to return to duty, but only after that resolution.
No. The collector documents the refusal at the collection site and notifies the DER. For situations involving adulteration or substitution, the MRO reports the outcome to the DER after reviewing the laboratory’s validity testing results. The DER acts on the notification received, not on personal observation of the refusal event.
The DER reports refusals to the FMCSA Clearinghouse within two business days of the refusal. This is the employer’s reporting obligation. It is distinct from positive drug and alcohol results, which are reported to the Clearinghouse by the MRO. DERs managing FMCSA-regulated programs should confirm their Clearinghouse reporting access and process before a refusal situation occurs.
